| Wednesday 7 March
|
|
08.15 10.15
|
|
Symposium 5: Novel endocrine consequences of stress
The identification of novel ligands for the CRF-R2 receptor has uncovered new roles for these receptors outside the CNS
Hall 1
Chairs: D Grammatopoulos (Coventry) & P Jamieson (Edinburgh)
|
| 08:15 |
S25
|
New roles for the CRF-R2
E Hillhouse (Edinburgh)
|
| 08:45 |
S26
|
Exercise alters endocrine and behavioural consequences of stress
J Reul ( (Bristol))
|
| 09:15 |
S27
|
Corticotropin releasing hormone system and inflammation
K Karalis ( (Boston, USA))
|
| 09:45 |
S28
|
Urocortins and peripheral energy metabolism
A Chen (Rehovot, Israel)
|
| |
|
|
|
08.15 10.15
|
|
Symposium 6: Vitamin D - new perspectives
Clinicopathological facets of vitamin D
Hall 1
Chairs: M Hewison (Los Angeles) & S Xu (Hull)
|
| 08:15 |
S29
|
The Vitamin D receptor as a dual-functional mediator of endocrine and detoxification pathways
P Thompson ( (Londonderry))
|
| 08:45 |
S30
|
The epithelial calcium channels: uniquely regulated gatekeepers
J Hoenderop ( (Nijmegan, The Netherlands))
|
| 09:15 |
S31
|
Vitamin D and Cancer Prevention
M Campbell ( (Birmingham))
|
| 09:45 |
S32
|
Vitamin D and autoimmune disease
C Mathieu ( (Leuven, Belgium))
|
| |
|
|
|
08.15 10.15
|
|
Nurses' Session 1: Thyroid cancer - more than a lump in the neck
Hall 9
Chairs: V Thornton-Jones (Oxford) & C Gibson (Manchester)
|
| 08:15 |
S60
|
Helping the patient through different types of thyroid cancer
R Dyer ( (Torquay))
|
| 08:45 |
S61
|
Controlling calcium following thyroidectomy
M Morris ( (Newcastle upon Tyne))
|
| 09:15 |
S62
|
Patient groups and the nurse's involvement
S Gorick ( (Norwich))
|
| 09:45 |
S63
|
The thyroid cancer patient journey and the role of the clinical nurse specialist
J Hewett ( (Torquay))
|
| |
|
|
|
10.15 10.45
|
|
Coffee
Hall 3
|
| |
|
|
|
10.45 11.30
|
|
Society for Endocrinology European Medal Lecture
GH and IGF-I have direct and indirect effects on the cardiovascular system. They act both on cardiomyocytes and on endothelial function. Consequently, alterations of the GH/IGF-1 axis induce cardiovascular diseases
Hall 1
Chair: J Wass (Oxford)
|
|
S4
|
GH/IGF-I and the cardiovascular system
A Colao (Naples, Italy)
|
| |
|
|
|
11:30 13:30
|
|
Lunch and attended posters
Posters 197-342 attended 12.00-12.30, all posters attended 12.30-13.00. Novartis award poster session 12.30
Hall 3
|
| |
|
|
|
13.30 15.30
|
|
Symposium 7: Animal disease, paradigm for human conditions
Aetiology, diagnosis and management of endocrine disease in domestic animals - any lesssons for human disease?
Hall 11
Chairs: J Bevan (Aberdeen) & D Church (Hatfield)
|
| 13:30 |
S33
|
Hyperadrenocorticism - current treatment options
D Church ( (Hatfield))
|
| 14:00 |
S34
|
Stress and sex on the farm - lessons for humans
H Dobson ( (Liverpool))
|
| 14:30 |
S35
|
Canine Diabetes Mellitus
B Catchpole ( (Hatfield))
|
| 15:00 |
S36
|
Feline hyperthyroidism: parallels with human hyperthyroidism
L Blackwood ( (Liverpool))
|
| |
|
|
|
13.30 15.30
|
|
Oral Communications 5: Thyroid and metabolism
Supported by the Clinical Endocrinology Trust
Hall 1
Chairs: J Newell-Price (Sheffield) & G Williams (London)
|
| 13:30 |
OC32
|
Extreme Insulin Resistance Syndromes - Beyond Glucose Homeostasis
Society for Endocrinology/Clinical Endocrinology Trust Young Endocrinologist Clinical Prize Lecture
R Semple;
|
| 14:00 |
OC33
|
Tag SNP screening of the PDCD1 gene for association with Graves’ disease
P Newby;
E Roberts-Davies;
O Brand;
J Heward;
J Franklyn;
S Gough;
M Simmonds;
|
| 14:15 |
OC34
|
Monocarboxylate transporter 8 (MCT8) represses proliferation of fetal embryonal NT2 and placental JEG-3 cells in vitro
British Thyroid Association award winner
S James;
C McCabe;
B Reaves;
V Smith;
S Chan;
T Barrett;
M Kilby;
J Franklyn;
|
| 14:30 |
OC35
|
A prothrombotic clot structure in hyperthyroidism: A mechanism for increased thrombosis in hyperthyroid individuals?
R Ajjan;
S Orme;
K Standeven;
F Phoenix;
V Hundia;
P Grant;
|
| 14:45 |
OC36
|
Comparsion of the NFκB and JNK mediated inflammatory mechanisms for production of adipocytokines in paired human epicardial and gluteo-femoral adipose tissue from CABG patients.
A Baker;
A Harte;
N da Silva;
M Hill;
A Ranasinghe;
K Khunti;
M Davies;
D Pagano;
R Bonser;
S Kumar;
P McTernan;
|
| 15:00 |
OC37
|
Testosterone replacement therapy attenuates fatty streak formation and improves the high-density lipoprotein cholesterol profile in the Testicular feminised (Tfm) mouse: an effect which is independent of the classical androgen receptor
J Nettleship;
R Jones;
K Channer;
H Jones;
|
| 15:15 |
OC38
|
The novel thyroid hormone derivative 3-iodothyronamine increases food intake via the hypothalamic arcuate nucleus
N White;
W Dhillo;
G Bewick;
J Gardiner;
J Scutt;
E Thompson;
A Kokkinos;
A Armstrong;
M Ghatei;
S Bloom;
|
| |
|
|
|
13:30 15:30
|
|
Nurses' Session 2: Dealing with MEN
Hall 9
Chairs: A Catteau (Sounthampton) & K Campbell (Glasgow)
|
|
|
Resumé
S Ball (Newcastle upon Tyne)
|
| 13:30 |
S64
|
Dealing with MEN: an overview
S Ball ( (Newcastle upon Tyne))
|
| 14:00 |
S65
|
Genetic counsellor contribution to the MEN patient
N Bradshaw ( (Glasgow))
|
| 14:30 |
S66
|
A paediatric perspective
L Martin ( (London))
|
| 15:00 |
S67
|
Adult Case
S Owusu-Antwi (London)
|
| |
|
|
|
15:30 16:00
|
|
Tea
Hall 3
|
| |
|
|
|
15:30 16:00
|
|
Nurses' Tea
Generously supported by Ipsen Ltd, poster boards by Novartis Oncology
Hall 1 level 5a
|
| |
|
|
|
16:00 17:00
|
|
The British Thyroid Association Pitt-Rivers Lecture - Incorporating Society for Endocrinology award ceremony
Thyroid hormone is well known to be important for growth and development. Recent studies of thyroid hormone receptors and deiodinases have revealed new developmental functions for this hormone, including sensory systems
Hall 1
Chair: A Weetman (Sheffield)
|
| 16:00 |
S5
|
Genes that mediate thyroid hormone functions in development
D Forrest ( (Bethesda, USA))
|
| |
|
|
|
17.00 17.45
|
|
Clinical Endocrinology Trust Visiting Professor Lecture
We have recently mapped an important polycystic ovary syndrome (PCOS) susceptibility allele. We propose that hyperandrogenemia resulting from variation in gene(s) regulation steroidogenesis contributes to PCOS reproductive and metabolic phenotypes by programming actions at critical periods of development as well as by ongoing actions in the adult.
Hall 1
Chair: L Rees (London)
|
|
S6
|
Genes and environment in the pathogenesis of polycystic ovary syndrome
A Dunaif ( (Chicago, USA))
|
| |
|
|
|
19.30
|
|
Society for Endocrinology Banquet
Burlington Hotel
|
| |
|
|